Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
Neurooncol Adv. 2021 Nov 30;3(1):vdab178.
doi: 10.1093/noajnl/vdab178.
eCollection 2021 Jan-Dec.
1 Division of Molecular Imaging and Therapeutics, Department of Radiology, NewYork-Presbyterian Hospital-Weill Cornell Campus, New York, New York, USA.
2 Department of Breast Oncology, NewYork-Presbyterian Hospital-Weill Cornell Campus, New York, New York, USA.
3 Department of Neurology, Weill Cornell Brain Tumor Center, NewYork-Presbyterian Hospital-Weill Cornell Campus, New York, New York, USA.
4 Department of Radiation Oncology, NewYork-Presbyterian Hospital-Weill Cornell Campus, New York, New York, USA.
5 Department of Neurological Surgery, NewYork-Presbyterian Hospital-Weill Cornell Campus, New York, New York, USA.